Shared and Distinct Molecular signatures of Resistance to different Endocrine therapies (Alliance A011106)
   Google Scholar   
Citation:
Meeting Instance:
ASCO 2026
Year:
2026
Type:
Abstract
Sub type:
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
Genentech, Astrazeneca  
Grants:
 
Corr. Author:
 
Authors:
                                           
Networks:
LAPS-MA036, LAPS-MO011, METROMIN, NC007, TX041   
Study
Alliance-A011106
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: